Tara Renée Heitner Hansen
Founder at Abarceo AB
Network origin in Tara Renée Heitner Hansen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 6 | |
Abarceo AB
 Abarceo AB Miscellaneous Commercial ServicesCommercial Services Abarceo AB develops novel therapeutics for type-2 diabetes. It identifies a novel diabetes target located on beta cells and a novel mechanism of action enabling a therapeutic treatment to revert beta cells from dysfunctional to functional, preserving beta cell function and allowing patients to produce insulin naturally. The company was founded by Tara Heitner, Claes Wollheim, and Albert Salehi in December 2017 and is headquartered in Malmo, Sweden.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
iSD Immunotech ApS
 iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark.
3
| Holding Company | Biotechnology | 3 |
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018.
3
| Private Company | Pharmaceuticals: Major | 3 |
Nordic Pharma Licensing Group
2
| Private Company | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Tara Renée Heitner Hansen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member | |
| University of Aarhus | College/University | Corporate Officer/Principal | |
Rijnconsult BV
 Rijnconsult BV Miscellaneous Commercial ServicesCommercial Services Rijnconsult BV specializes in management consulting and interim management services. The private company is based in Houten, Netherlands. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Stockholm | College/University | Doctorate Degree | |
| University of Lund | College/University | Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
| MENTICE AB | Medical Specialties | Director of Finance/CFO | |
PricewaterhouseCoopers (Denmark)
 PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a private company based in Hellerup, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Gothenburg | College/University | Doctorate Degree | |
| MAGFORCE AG | Medical Specialties | Founder | |
| University of Kalmar | College/University | Masters Business Admin | |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Analyst | |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
KPMG Danmark A/S
 KPMG Danmark A/S Miscellaneous Commercial ServicesCommercial Services KPMG Danmark A/S provides audit, tax, and advisory services. The private company is based in Copenhagen, Denmark, and has subsidiaries in Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Miscellaneous Commercial Services | Founder | |
| University of Linnaeus | College/University | Undergraduate Degree | |
| ULTIMOVACS ASA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Ideonfonden AB | Chief Executive Officer | ||
| XINTELA AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Saxion University of Applied Sciences | College/University | Undergraduate Degree | |
| GABATHER AB | Pharmaceuticals: Major | Director of Finance/CFO | |
| OBOYA HORTICULTURE INDUSTRIES AB (PUBL) | Miscellaneous Commercial Services | Director of Finance/CFO | |
| Lund University School of Economics & Management | College/University | Masters Business Admin | |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member | |
| INVENT MEDIC SWEDEN AB | Medical Specialties | Director of Finance/CFO | |
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Chief Executive Officer | |
Merck Ventures BV
 Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Analyst | |
Gedea Biotech AB
 Gedea Biotech AB Miscellaneous Commercial ServicesCommercial Services Gedea Biotech AB provides drugs for the treatment of bacterial and fungal diseases. It develops an antibiotic-free treatment for vaginal fungal infections. The company was founded by Olov Arvid Sterner, Ingrid Helena Strevens, Ulf Christian Ellervik, and Sophie Margareta Manner and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Chairman | |
Ledningsresurs Syd AB
 Ledningsresurs Syd AB Miscellaneous Commercial ServicesCommercial Services Ledningsresurs Syd AB provides corporate consulting services. Ola Skanung has been the CEO of the Swedish company since 2010. | Miscellaneous Commercial Services | Chief Executive Officer | |
ADCendo ApS
 ADCendo ApS BiotechnologyHealth Technology ADCendo ApS is a Danish company that is focused on developing antibody-drug conjugates (ADCs) to treat underserved cancers. The company is based in Humlebaek, Denmark. The company completed a series A extension financing round in 2023, which brought its funds to 82 million EUR to advance into clinical development. The investors in the company include Novo Holdings, Ysios Capital, Pontifax Venture Capital, RA Capital Management, HealthCap, and Gilde Healthcare. The company was founded in 2017 by Christoffer Nielsen, Henrik Stage. Michael Pehl has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Oboya Horti Supplies AB
 Oboya Horti Supplies AB Wholesale DistributorsDistribution Services Oboya Horti Supplies AB is a Swedish company that wholesales chemical products. | Wholesale Distributors | Corporate Officer/Principal | |
| Flugsvampen Hhy AB | Chairman | ||
| Pig Sverige AB | Chairman | ||
| Classic Beauty Invest AB | Corporate Officer/Principal | ||
| Classic Beauty Göteborg AB | Corporate Officer/Principal | ||
| XO Sweden Wines & Spirits AB | Director/Board Member | ||
| FLUOGUIDE A/S | Pharmaceuticals: Major | Director of Finance/CFO | |
Rappta Therapeutics Oy
 Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Biotechnology | Director/Board Member | |
| Immodulate Pharma AB | Chief Executive Officer | ||
| UCB Nordic AS | Director/Board Member |
Statistics
International
| Sweden | 26 |
| Denmark | 15 |
| United Kingdom | 3 |
| Netherlands | 3 |
| Germany | 3 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 9 |
| Commercial Services | 9 |
| Finance | 4 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 32 |
| Corporate Officer/Principal | 25 |
| Chief Executive Officer | 13 |
| Chairman | 12 |
| Founder | 11 |
Most connected contacts
- Stock Market
- Insiders
- Tara Renée Heitner Hansen
- Company connections